The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.
Targeted Therapy for Skin Malignancies: Basal Cell Carcinoma, Melanoma, and Merkel Cell
| Overview / Abstract: |
Patients may not always be offered the most appropriate single and combination targeted therapies that have been proven effective in clinical trials. Currently available clinical data have practice-changing implications for medical oncologists, dermatologists, and related specialists treating skin malignancies. To stay up to date with the latest data, evidence will be presented related to the role of BRAF inhibition, hedgehog signaling, and immunotherapy in the pathogenesis and treatment of basal cell carcinoma (BCC), melanoma, and Merkel cell cancers. Participants will have the opportunity to consider the potential benefits and side effects, in order to ensure that patients reach or maintain their treatment and quality-of-life goals. |
|
Expiration |
Feb 06, 2019 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
AACME - 1.25 AMA PRA Category 1 Credit(s) TM, ACPE - 1.25 hours (0.125 CEUs), ANCC - 1.1 contact hours. Designated for 0.9 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses. |
|
Accreditation |
AACME, ACPE, ANCC, APRN |
|
Presenters / Authors / Faculty |
Sanjiv S. Agarwala, MD |
|
Activity Specialities / Related Topics |
Dermatology, Hematology, Oncology / Cancer / Radiation Therapy |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by independent educational grants from AstraZeneca, Genentech, Lilly, and Novartis Pharmaceuticals Corporation. For further information concerning Lilly grant funding visit www.lillygrantoffice.com. |
|
Keywords / Search Terms |
Rockpointe Free CME, CME, CE, Nurses, Registered Nurses, Nurse Practitioners, RN, NP, APN, Pharmacy, Pharmacist, Oncology, Hematolgy, dermatology, skin malignancies, Free CE CME |
|